Entheon Biomedical Corp. (ENTBF)
- Previous Close
0.1222 - Open
0.1157 - Bid --
- Ask --
- Day's Range
0.1157 - 0.1157 - 52 Week Range
0.0040 - 0.2000 - Volume
505 - Avg. Volume
5,839 - Market Cap (intraday)
1.102M - Beta (5Y Monthly) 1.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Jul 22, 2024 - Jul 26, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Entheon Biomedical Corp. operates as a biotechnology research and development company. It engages in developing of products for treating addiction and substance use disorders. The company is headquartered in Vancouver, Canada.
www.entheonbiomedical.comRecent News: ENTBF
Performance Overview: ENTBF
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ENTBF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ENTBF
Valuation Measures
Market Cap
1.10M
Enterprise Value
914.63k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.18
Price/Book (mrq)
5.82
Enterprise Value/Revenue
9.64
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-214.29%
Return on Assets (ttm)
-36.67%
Return on Equity (ttm)
-73.36%
Revenue (ttm)
130.32k
Net Income Avi to Common (ttm)
-279.27k
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
249.92k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-172.11k